Analystreport

TRACON Pharmaceuticals (NASDAQ: TCON) had its price target lowered by analysts at Needham & Company LLC to $8.00. They now have a "buy" rating on the stock.

TRACON Pharmaceuticals, Inc.  (TCON) 
Last tracon pharmaceuticals, inc. earnings: 2/27 04:03 pm Check Earnings Report
US:NASDAQ Investor Relations: traconpharma.com